Literature DB >> 31602897

[Research progress on chemical constituents and quality control of Tripterygium wilfordii preparations].

Ya-Dan Wang1, Qi Wang1, Jian-Bao Zhang2, Zhong Dai1, Na Lin3, Xian-Fu Wu1, Shuang-Cheng Ma1.   

Abstract

Tripterygium wilfordii preparations,with various biological activities such as immunosuppressive,anti-inflammatory and anti-cancer effects,are widely used in the treatment of autoimmune diseases such as rheumatoid arthritis,lupus erythematosus,and nephrotic syndrome. They have definite therapeutic effect,but often cause serious adverse reactions and result in damages to liver,kidney,blood,reproduction,and other systems due to their complex compositions,great toxicity,and narrow margin between the toxic and therapeutic dosages. At present,T. wilfordii preparations produced by different manufacturers exhibit large variations in clinical efficacy and side effects in account of their different chemical compositions and quality fluctuation due to differences in raw materials and production process. However,the existing quality standards are controversial in terms of index components and content limit,which cannot be effectively used for the overall quality control of the preparations. In this paper,the research progress on chemical constituents,quality standard and quality control methods of four T. wilfordii preparations including Tripterygium Tablets,Tripterygium Zongtie Tablets,Tripterygium Shuangceng Tablets and Tripterygium Glycosides Tablets was reviewed,in order to provide ideas and reference for the quality improvement of this type of preparations.

Entities:  

Keywords:  Tripterygium wilfordii preparations; chemical composition; quality control; quality standard

Mesh:

Substances:

Year:  2019        PMID: 31602897     DOI: 10.19540/j.cnki.cjcmm.20190606.501

Source DB:  PubMed          Journal:  Zhongguo Zhong Yao Za Zhi        ISSN: 1001-5302


  1 in total

Review 1.  Applications and Mechanisms of Tripterygium Wilfordii Hook. F. and its Preparations in Kidney Diseases.

Authors:  Xue Tong; Yanheng Qiao; Yuanjian Yang; Haizhao Liu; Zhiyong Cao; Bo Yang; Lijuan Wei; Hongtao Yang
Journal:  Front Pharmacol       Date:  2022-03-21       Impact factor: 5.810

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.